A Study in Maintenance Kidney Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based

NCT01820572 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

446

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Transplantation

Interventions

DRUG: Belatacept
DRUG: Tacrolimus
DRUG: Cyclosporine

Sponsor

Bristol-Myers Squibb